Payer Considerations for Selecting Breast Cancer Medications
Dr Mullangi, MD, MBA, discusses cost perspectives in selecting breast cancer treatments.
Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr Mullangi, MD, MBA, discusses cost perspectives in selecting breast cancer treatments.
/PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that the U.S. Food and Drug Administration...
/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy— the first daily...
The FDA approved the first birth control pill available without a prescription, expanding access to contraceptives. It will hit shelves in 2024.
Novo Nordisk on Thursday accused three Florida pharmacies of illegally selling products claiming to contain semaglutide, the active ingredient in the Danish drugmaker's weight loss and diabetes drugs Wegovy, Ozempic and Rybelsus. In three separate lawsuits in Florida federal court, Novo Nordisk sought orders barring TruLife Pharmacy, Brooksville Pharmaceuticals and WellHealth Inc from selling the products, and seeking unspecified money damages.